HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masafumi Matsuo Selected Research

Hemolytic-Uremic Syndrome

4/2007Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
8/2004Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masafumi Matsuo Research Topics

Disease

67Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2022 - 01/2002
14Neoplasms (Cancer)
01/2017 - 09/2002
13Wasting Syndrome (Wasting Disease)
01/2022 - 05/2006
9Muscular Dystrophies (Muscular Dystrophy)
01/2020 - 12/2006
6Hereditary Nephritis (Alport Syndrome)
01/2022 - 12/2006
5Intellectual Disability (Idiocy)
09/2016 - 09/2002
5Glucosephosphate Dehydrogenase Deficiency
06/2005 - 08/2002
4Insulin Resistance
08/2015 - 02/2003
4Neuroblastoma
03/2015 - 07/2011
3Gitelman Syndrome
09/2022 - 04/2007
3Hepatocellular Carcinoma (Hepatoma)
08/2021 - 02/2003
3Body Weight (Weight, Body)
10/2020 - 08/2004
3Glioblastoma (Glioblastoma Multiforme)
05/2020 - 01/2019
3Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 02/2003
3Sepsis (Septicemia)
12/2014 - 06/2009
3Gilbert Disease
12/2012 - 08/2002
3Neoplasm Metastasis (Metastasis)
12/2007 - 12/2004
3Proteinuria
12/2006 - 11/2005
3Neonatal Jaundice
06/2005 - 08/2002
3Adenocarcinoma
12/2004 - 01/2002
3Malaria
01/2003 - 01/2003
2Rhabdomyosarcoma
04/2022 - 05/2018
2Walker-Warburg Syndrome
10/2021 - 01/2021
2Critical Illness (Critically Ill)
02/2021 - 01/2020
2Muscular Atrophy (Muscle Atrophy)
02/2021 - 01/2020
2Muscular Diseases (Myopathy)
01/2018 - 01/2017
2Hypercalciuria
12/2017 - 08/2007
2Inborn Genetic Diseases (Disease, Hereditary)
12/2017 - 10/2003
2Acidosis
12/2017 - 11/2009
2Nephrocalcinosis
12/2017 - 08/2007
2Lymphoma (Lymphomas)
03/2015 - 01/2007
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2014 - 11/2005
2Tuberous Sclerosis (Bourneville's Disease)
06/2011 - 05/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2010 - 01/2007
2Breast Neoplasms (Breast Cancer)
08/2010 - 01/2007
2Bartter Syndrome (Syndrome, Bartter)
10/2009 - 09/2007
2Spinal Muscular Atrophy (Progressive Muscular Atrophy)
03/2009 - 02/2007
2Maple Syrup Urine Disease
06/2008 - 02/2004
2Hemolytic-Uremic Syndrome
04/2007 - 08/2004
2Nephrotic Syndrome (Syndrome, Nephrotic)
11/2005 - 07/2005
2Hemolysis
06/2005 - 03/2005
2Jaundice (Icterus)
06/2005 - 08/2002
1Birth Weight (Birth Weights)
01/2022
1Diamond-Blackfan Anemia (Anemia, Diamond Blackfan)
09/2021
1Rare Diseases (Rare Disease)
07/2021

Drug/Important Bio-Agent (IBA)

56DystrophinIBA
01/2022 - 01/2002
17Messenger RNA (mRNA)IBA
01/2022 - 01/2002
16Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2003
10Antisense OligonucleotidesIBA
09/2021 - 08/2004
9Protein Isoforms (Isoforms)IBA
01/2022 - 07/2011
9ConnectinIBA
01/2022 - 12/2016
9Nonsense Codon (Nonsense Mutation)IBA
09/2021 - 03/2004
5Biomarkers (Surrogate Marker)IBA
02/2021 - 06/2012
5DNA (Deoxyribonucleic Acid)IBA
12/2014 - 01/2002
4RNA Precursors (Precursor, mRNA)IBA
09/2021 - 10/2011
4Pharmaceutical PreparationsIBA
10/2020 - 03/2004
4Complementary DNA (cDNA)IBA
05/2020 - 05/2004
3SaltsIBA
09/2022 - 10/2009
3MyostatinIBA
04/2022 - 04/2007
3EnzymesIBA
01/2019 - 06/2008
3RNA (Ribonucleic Acid)IBA
03/2015 - 08/2004
3Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
08/2010 - 12/2002
3Oxidoreductases (Dehydrogenase)IBA
06/2008 - 08/2004
3Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
02/2003 - 01/2003
2ChloridesIBA
09/2022 - 12/2010
2Insulin ReceptorIBA
08/2021 - 08/2015
2Uric Acid (Urate)IBA
01/2020 - 12/2009
2dirhodium tetraacetate (DRTA)IBA
12/2017 - 01/2003
2Small Interfering RNA (siRNA)IBA
03/2015 - 02/2013
2Rituximab (Mabthera)FDA Link
12/2014 - 11/2005
2Creatine Kinase (Creatine Phosphokinase)IBA
06/2012 - 10/2010
2Monomeric GTP-Binding ProteinsIBA
06/2012 - 07/2011
2trans-sodium crocetinate (crocetin)IBA
06/2011 - 05/2008
2SteroidsIBA
04/2011 - 02/2006
2BilirubinIBA
01/2011 - 08/2002
2Collagen Type IV (Type IV Collagen)IBA
10/2010 - 08/2008
2Glutathione Transferase (Glutathione S-Transferase)IBA
08/2010 - 01/2007
2Reduced Folate Carrier ProteinIBA
08/2010 - 01/2007
2Codon (Codons)IBA
03/2010 - 10/2004
2Glucose (Dextrose)FDA LinkGeneric
12/2009 - 06/2005
2AldosteroneIBA
11/2009 - 12/2006
2Immunoglobulin E (IgE)IBA
06/2009 - 01/2005
2Testosterone (Sustanon)FDA Link
06/2009 - 01/2007
2GonadotropinsIBA
06/2009 - 01/2007
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2007 - 07/2005
2NucleotidesIBA
04/2007 - 01/2002
2Uridine Diphosphate (UDP)IBA
01/2006 - 08/2002
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2006 - 08/2002
2Anti-Bacterial Agents (Antibiotics)IBA
09/2005 - 04/2004
2AminoglycosidesIBA
09/2005 - 04/2004
2Multidrug Resistance-Associated ProteinsIBA
03/2004 - 01/2002
2multidrug resistance-associated protein 1IBA
03/2004 - 01/2002
2Fluorouracil (Carac)FDA LinkGeneric
10/2003 - 09/2002
2Cytochrome P-450 CYP3AIBA
02/2003 - 01/2002
1Dystroglycans (Dystroglycan)IBA
10/2021
1Ribosomal Proteins (Ribosomal Protein)IBA
09/2021

Therapy/Procedure

16Therapeutics
07/2021 - 03/2002
4Drug Therapy (Chemotherapy)
03/2015 - 09/2002
4Ligation
06/2013 - 01/2004
1Precision Medicine
07/2021